Advancing Alzheimer's Therapeutics: Exploring the Impact of Physical Exercise in Animal Models and Patients.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
27 Oct 2023
Historique:
received: 26 09 2023
revised: 18 10 2023
accepted: 25 10 2023
medline: 13 11 2023
pubmed: 10 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

Alzheimer's disease (AD) is the main neurodegenerative disorder characterized by several pathophysiological features, including the misfolding of the tau protein and the amyloid beta (Aβ) peptide, neuroinflammation, oxidative stress, synaptic dysfunction, metabolic alterations, and cognitive impairment. These mechanisms collectively contribute to neurodegeneration, necessitating the exploration of therapeutic approaches with multiple targets. Physical exercise has emerged as a promising non-pharmacological intervention for AD, with demonstrated effects on promoting neurogenesis, activating neurotrophic factors, reducing Aβ aggregates, minimizing the formation of neurofibrillary tangles (NFTs), dampening inflammatory processes, mitigating oxidative stress, and improving the functionality of the neurovascular unit (NVU). Overall, the neuroprotective effects of exercise are not singular, but are multi-targets. Numerous studies have investigated physical exercise's potential in both AD patients and animal models, employing various exercise protocols to elucidate the underlying neurobiological mechanisms and effects. The objective of this review is to analyze the neurological therapeutic effects of these exercise protocols in animal models and compare them with studies conducted in AD patients. By translating findings from different approaches, this review aims to identify opportune, specific, and personalized therapeutic windows, thus advancing research on the use of physical exercise with AD patients.

Identifiants

pubmed: 37947609
pii: cells12212531
doi: 10.3390/cells12212531
pmc: PMC10648553
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : UNAM-PAPIIT
ID : IA205423, IN206322
Organisme : Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCYT), Ciencia Básica y/o Ciencia de Frontera Modalidad: Paradigmas y Controversias de la Ciencia 2022
ID : 319433

Références

Front Psychol. 2012 Mar 23;3:86
pubmed: 22470361
Yonsei Med J. 2017 May;58(3):479-488
pubmed: 28332351
Indian J Psychiatry. 2009 Jan;51(1):12-25
pubmed: 19742190
Neurosci Res. 2022 May;178:60-68
pubmed: 35033583
Brain Pathol. 2006 Oct;16(4):295-303
pubmed: 17107599
Trends Cogn Sci. 2013 Oct;17(10):525-44
pubmed: 24029446
Brain Res. 2003 May 9;971(2):197-209
pubmed: 12706236
Biomedicines. 2022 Jan 28;10(2):
pubmed: 35203515
Braz J Med Biol Res. 2011 Nov;44(11):1070-9
pubmed: 21952737
Int J Mol Med. 2008 Oct;22(4):529-39
pubmed: 18813861
Nutrients. 2022 Oct 05;14(19):
pubmed: 36235786
Maturitas. 2019 Aug;126:28-33
pubmed: 31239114
J Aging Phys Act. 2018 Jul 1;26(3):353-362
pubmed: 28952854
Brain Sci. 2021 Jan 06;11(1):
pubmed: 33419016
Mol Neurobiol. 2021 Sep;58(9):4217-4225
pubmed: 33963521
Dement Neuropsychol. 2023 May 29;17:e20220008
pubmed: 37261252
Neurol Clin. 2007 Aug;25(3):577-609, v
pubmed: 17659182
Neurobiol Dis. 2011 Aug;43(2):486-94
pubmed: 21569847
Int J Mol Sci. 2023 Feb 13;24(4):
pubmed: 36835161
Afr Health Sci. 2016 Dec;16(4):1045-1055
pubmed: 28479898
Neurobiol Stress. 2018 Feb 22;8:158-171
pubmed: 29888311
Brain Pathol. 2010 Jan;20(1):166-75
pubmed: 19134003
Eur J Appl Physiol. 2020 Oct;120(10):2233-2245
pubmed: 32728820
Ann Neurol. 2010 Sep;68(3):311-8
pubmed: 20818789
Acad Radiol. 2021 Oct;28(10):1447-1463
pubmed: 32651050
Neuroimage Clin. 2018 Sep 04;20:650-654
pubmed: 30211001
Arch Phys Med Rehabil. 2004 Oct;85(10):1694-704
pubmed: 15468033
Pflugers Arch. 2007 Jan;453(4):497-507
pubmed: 17093970
Physiol Rep. 2020 Sep;8(17):e14502
pubmed: 32889774
Nat Neurosci. 1999 Mar;2(3):266-70
pubmed: 10195220
Nat Rev Endocrinol. 2017 Mar;13(3):133-148
pubmed: 27739515
J Exerc Rehabil. 2023 Feb 23;19(1):27-34
pubmed: 36910679
J Sport Health Sci. 2020 Jan;9(1):53-73
pubmed: 31921481
Eur Rev Aging Phys Act. 2020 Jan 06;17:2
pubmed: 31921371
Neurosci Lett. 2016 Jan 1;610:207-12
pubmed: 26592481
J Am Med Dir Assoc. 2020 Oct;21(10):1415-1422.e6
pubmed: 32981668
Metab Brain Dis. 2022 Jan;37(1):39-50
pubmed: 34406560
Aten Primaria. 2020 May;52(5):307-318
pubmed: 31153668
CNS Neurol Disord Drug Targets. 2010 Apr;9(2):156-67
pubmed: 20205644
Am J Geriatr Psychiatry. 2020 May;28(5):587-589
pubmed: 31444046
Ann Neurol. 2018 Mar;83(3):544-552
pubmed: 29406582
J Neuroinflammation. 2020 Sep 15;17(1):271
pubmed: 32933545
Neurobiol Dis. 2009 Sep;35(3):426-32
pubmed: 19524672
Med Sci Sports Exerc. 2015 Sep;47(9):1814-24
pubmed: 25574797
Braz J Med Biol Res. 2012 Dec;45(12):1215-20
pubmed: 22930413
Neural Regen Res. 2022 Sep;17(9):2079-2088
pubmed: 35142700
J Sport Health Sci. 2020 Sep;9(5):394-404
pubmed: 32780691
Ageing Res Rev. 2016 May;27:77-92
pubmed: 27039886
J Neurosci. 2005 Apr 27;25(17):4217-21
pubmed: 15858047
Neurochem Int. 2022 May;155:105309
pubmed: 35276288
Stem Cell Reports. 2021 Apr 13;16(4):681-693
pubmed: 33636114
Cells. 2021 Jun 18;10(6):
pubmed: 34207393
Mol Neurodegener. 2014 Nov 28;9:54
pubmed: 25432085
Neurosci Biobehav Rev. 2021 Sep;128:394-405
pubmed: 34087277
Int J Mol Sci. 2023 Jul 06;24(13):
pubmed: 37446312
Transl Neurodegener. 2022 Jan 28;11(1):4
pubmed: 35090576
Int J Mol Sci. 2021 Aug 13;22(16):
pubmed: 34445419
Antioxidants (Basel). 2022 May 23;11(5):
pubmed: 35624892
Front Aging Neurosci. 2021 Jun 14;13:646807
pubmed: 34194314
Brain Plast. 2018 Dec 12;4(1):17-52
pubmed: 30564545
Mol Psychiatry. 2013 Aug;18(8):864-74
pubmed: 23164816
PLoS One. 2021 Jan 14;16(1):e0244893
pubmed: 33444359
Restor Neurol Neurosci. 2017;35(5):547-556
pubmed: 28984621
Neurobiol Aging. 2014 Sep;35 Suppl 2:S20-8
pubmed: 24952993
Front Mol Neurosci. 2017 Dec 19;10:427
pubmed: 29311817
Brain Plast. 2018 Dec 12;4(1):127-150
pubmed: 30564551
Exp Gerontol. 2021 Oct 1;153:111502
pubmed: 34339821
Front Neurosci. 2020 Nov 05;14:530219
pubmed: 33250703
Brain. 2018 Jul 1;141(7):1917-1933
pubmed: 29850777
J Prev Alzheimers Dis. 2019;6(1):2-15
pubmed: 30569080
Mol Cell Biochem. 2010 Dec;345(1-2):91-104
pubmed: 20730621
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10487-10492
pubmed: 30249651
Behav Brain Res. 2021 Jan 1;396:112903
pubmed: 32937170
PLoS One. 2016 Nov 10;11(11):e0165460
pubmed: 27832087
J Pathol. 2018 May;245(1):85-100
pubmed: 29435980
Mol Neurobiol. 2019 Nov;56(11):7534-7556
pubmed: 31062248
Front Neurosci. 2023 Apr 06;17:1132825
pubmed: 37090809
Front Aging Neurosci. 2022 May 18;14:869507
pubmed: 35663578
Int J Mol Sci. 2021 Feb 18;22(4):
pubmed: 33670754
Nat Rev Neurosci. 2019 Apr;20(4):235-245
pubmed: 30723309
J Sport Health Sci. 2020 May;9(3):211-227
pubmed: 32444146
Brain Plast. 2018 Dec 12;4(1):81-94
pubmed: 30564548
Arch Pharm Res. 2019 May;42(5):416-425
pubmed: 30830660
Clin Interv Aging. 2018 Sep 04;13:1593-1603
pubmed: 30233156
J Neuroinflammation. 2020 Jan 3;17(1):4
pubmed: 31900170
Physiol Rev. 2021 Jul 1;101(3):1047-1081
pubmed: 33475022
Brain. 2016 Mar;139(Pt 3):662-73
pubmed: 26912638
Biomedicines. 2021 Sep 01;9(9):
pubmed: 34572312
Trends Cogn Sci. 2019 Apr;23(4):318-333
pubmed: 30777641
Psychol Sci. 2003 Mar;14(2):125-30
pubmed: 12661673
Alzheimers Res Ther. 2022 Sep 30;14(1):143
pubmed: 36180883
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Neurosci. 2021 Mar 24;41(12):2541-2553
pubmed: 33762406
J Neuroinflammation. 2023 Mar 19;20(1):76
pubmed: 36935511
Ageing Res Rev. 2018 Dec;48:109-121
pubmed: 30326283
Tissue Barriers. 2013 Apr 1;1(2):e23993
pubmed: 24665385
Int J Mol Sci. 2018 Jan 02;19(1):
pubmed: 29301328
J Int Neuropsychol Soc. 2015 Nov;21(10):841-50
pubmed: 26581795
Biomed Res Int. 2018 Jan 30;2018:7212861
pubmed: 29662895
Nat Rev Endocrinol. 2022 May;18(5):273-289
pubmed: 35304603
Int J Geriatr Psychiatry. 2019 Sep;34(9):1316-1325
pubmed: 30156330
Oxid Med Cell Longev. 2017;2017:5414297
pubmed: 29181126
Am J Physiol. 1994 Sep;267(3 Pt 2):H1167-73
pubmed: 8092282
Nat Rev Cardiol. 2018 Dec;15(12):731-743
pubmed: 30115967
Mol Neurobiol. 2016 Jan;53(1):648-661
pubmed: 25511446
J Alzheimers Dis. 2017;57(4):1105-1121
pubmed: 28059794
Behav Brain Res. 2017 Jun 15;328:159-177
pubmed: 28390878
EMBO J. 2018 Jan 17;37(2):167-182
pubmed: 29229786
Rev Neurol. 2006 Mar 16-31;42(6):350-3
pubmed: 16575771
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Exp Neurol. 2023 May;363:114371
pubmed: 36871860
Ageing Res Rev. 2020 Sep;62:101108
pubmed: 32561386
Exp Gerontol. 2019 Jul 1;121:91-98
pubmed: 30980923
J Neurosci Res. 2009 Aug 15;87(11):2561-70
pubmed: 19360903
Cond Med. 2017;1(1):27-34
pubmed: 30465042
Aging Dis. 2022 Jul 11;13(4):1293-1310
pubmed: 35855335
Int J Mol Sci. 2022 Oct 21;23(20):
pubmed: 36293516
Physiol Rep. 2021 Jun;9(11):e14851
pubmed: 34110704
Diabetes Res Clin Pract. 2021 Mar;173:108700
pubmed: 33600868
J Gerontol A Biol Sci Med Sci. 2016 Jan;71(1):40-9
pubmed: 25720862
Neurol Clin Pract. 2018 Jun;8(3):257-265
pubmed: 30105166
Expert Rev Neurother. 2016 Jun;16(6):723-34
pubmed: 27086703
J Phys Act Health. 2018 Jun 1;15(6):403-410
pubmed: 29542360
Front Neurol. 2018 Dec 13;9:1058
pubmed: 30619031
Nat Rev Neurosci. 2006 Sep;7(9):697-709
pubmed: 16924259
Science. 2018 Sep 7;361(6406):
pubmed: 30190379
Brain Pathol. 2016 Jan;26(1):62-74
pubmed: 25763997
Int J Mol Sci. 2021 Feb 25;22(5):
pubmed: 33668976
Alzheimers Dement (Amst). 2018 Feb 06;10:188-195
pubmed: 29527551
Brain Behav Immun. 2006 May;20(3):201-9
pubmed: 16504463
Oxid Med Cell Longev. 2022 Feb 2;2022:1764589
pubmed: 35154563
Comp Med. 2011 Aug;61(4):314-21
pubmed: 22330246
J Alzheimers Dis. 2018;61(1):359-372
pubmed: 29154278
Obes Rev. 2023 Oct;24(10):e13599
pubmed: 37416977
Neuroimage Clin. 2020;25:102182
pubmed: 31978826
J Am Geriatr Soc. 2018 Mar;66(3):487-495
pubmed: 29363108
J Alzheimers Dis. 2020;75(2):617-631
pubmed: 32310162
Behav Brain Res. 2019 Nov 18;374:112105
pubmed: 31325514
Curr Neuropharmacol. 2017;15(4):519-533
pubmed: 27000776
Neurobiol Aging. 2020 May;89:132-141
pubmed: 31324405
Int J Older People Nurs. 2020 Mar;15(1):e12287
pubmed: 31750628
J Alzheimers Dis. 2020;73(4):1525-1539
pubmed: 31958083
J Exerc Rehabil. 2023 Jun 28;19(3):141-148
pubmed: 37435589
Alzheimers Dement. 2023 Feb;19(2):507-517
pubmed: 35476309
Neuroreport. 2019 May 1;30(7):498-503
pubmed: 30882716
Int J Mol Sci. 2021 Oct 25;22(21):
pubmed: 34768919
Exp Gerontol. 2018 Sep;110:284-290
pubmed: 29958998
Mol Neurodegener. 2019 Aug 2;14(1):32
pubmed: 31375134
Am J Phys Med Rehabil. 2011 Jun;90(6):452-65
pubmed: 21273898
Oxid Med Cell Longev. 2021 Nov 25;2021:3898710
pubmed: 34868454
J Alzheimers Dis. 2019;70(s1):S187-S205
pubmed: 30372680
Int J Mol Sci. 2020 Aug 16;21(16):
pubmed: 32824367
J Alzheimers Dis. 2017;56(4):1469-1484
pubmed: 28157094
Occup Ther Int. 2020 Jul 30;2020:6305727
pubmed: 32821251
Med Sci Sports Exerc. 2018 May;50(5):945-956
pubmed: 29232315
Brain Pathol. 2016 Sep;26(5):648-63
pubmed: 27328058
Int J Mol Sci. 2023 Feb 15;24(4):
pubmed: 36835277
PLoS One. 2018 Jan 2;13(1):e0190205
pubmed: 29293568
J Physiol. 2001 Sep 1;535(Pt 2):313-22
pubmed: 11533125
Alzheimer Dis Assoc Disord. 2020 Jul-Sep;34(3):212-219
pubmed: 32520736

Auteurs

Jesús Andrade-Guerrero (J)

Laboratorio de Patogénesis Molecular, Laboratorio 4, Edificio A4, Carrera Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Queretaro 76230, Mexico.

Paola Rodríguez-Arellano (P)

Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Queretaro 76230, Mexico.

Nayeli Barron-Leon (N)

Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Queretaro 76230, Mexico.

Erika Orta-Salazar (E)

Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Queretaro 76230, Mexico.

Carlos Ledesma-Alonso (C)

Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Queretaro 76230, Mexico.

Sofía Díaz-Cintra (S)

Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Queretaro 76230, Mexico.

Luis O Soto-Rojas (LO)

Laboratorio de Patogénesis Molecular, Laboratorio 4, Edificio A4, Carrera Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Red MEDICI, Carrera Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH